Skip to main content
Top
Metadata
Title
Expressions of FEZ1 and Survivin, and their significance in small cell lung cancer and squamous cell lung carcinoma
Authors
Gang Chen
Xiaoling Wang
Yueping Liu
Lining Wang
Huichai Yang
Huijun Duan
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
The Chinese-German Journal of Clinical Oncology / Issue 4/2008
Print ISSN: 1610-1979
Electronic ISSN: 1613-9089
DOI
https://doi.org/10.1007/s10330-008-0010-6

Other articles of this Issue 4/2008

The Chinese-German Journal of Clinical Oncology 4/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine